{
    "organizations": [],
    "uuid": "40f112027c8c3ccd5bb98afc729f138ccae36465",
    "author": "",
    "url": "https://www.reuters.com/article/brief-avenue-therapeutics-reports-q1-los/brief-avenue-therapeutics-reports-q1-loss-per-share-of-1-03-idUSASC09ZHV",
    "ord_in_thread": 0,
    "title": "BRIEF-Avenue Therapeutics Reports Q1 Loss Per Share Of $1.03",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 3, 2018 / 11:44 AM / Updated 2 minutes ago BRIEF-Avenue Therapeutics Reports Q1 Loss Per Share Of $1.03 Reuters Staff\nMay 3 (Reuters) - Avenue Therapeutics Inc:\n* AVENUE THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND RECENT CORPORATE HIGHLIGHTS * Q1 LOSS PER SHARE $1.03\n* AS OF MARCH 31, 2018, CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS TOTALED $15.0 MILLION Source text for Eikon: Further company coverage:",
    "published": "2018-05-03T14:42:00.000+03:00",
    "crawled": "2018-05-03T14:52:42.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "report",
        "q1",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "may",
        "reuters",
        "avenue",
        "therapeutic",
        "inc",
        "avenue",
        "therapeutic",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "recent",
        "corporate",
        "highlight",
        "q1",
        "loss",
        "per",
        "share",
        "march",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "totaled",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}